Tulum, E. A. (2024). Using transcriptomics to inform the next generation risk assessment of doxorubicin and niacinamide.
Chicago Style (17th ed.) CitationTulum, Elizabeth Ann. Using Transcriptomics to Inform the Next Generation Risk Assessment of Doxorubicin and Niacinamide. 2024.
MLA (9th ed.) CitationTulum, Elizabeth Ann. Using Transcriptomics to Inform the Next Generation Risk Assessment of Doxorubicin and Niacinamide. 2024.
Warning: These citations may not always be 100% accurate.